The need to tame healthcare spending and stay on top of potential competition has led health insurers to pair up with nontraditional partners. Here's how the five dominant national insurers are reshaping themselves and the industry.
Many providers cite savings on services and supply chain as a sizable factor driving their mergers and acquisitions. But a new paper shows bundling purchases and standardization don't save as much as they think.
Lakeland Regional Health and Orlando Health lasted less than a year as integrated partners and will break up on Sept. 30.
The deal will allow TriMedx to expand its healthcare clientele and Aramark to focus on its core food, facilities and uniforms businesses, executives said.
Cigna and Express Scripts still must secure certain state regulatory approvals to complete the deal, but the nod from the federal antitrust enforcers takes care of the biggest hurdle.
Their union builds off an existing academic affiliation spanning two decades to create an 18-hospital system with about $5.9 billion in revenue.
Private equity firms increasingly see post-acute providers as lucrative investments, buying skilled-nursing and senior-housing facilities from REITs that are willing to sell because of the sectors' financial struggles.
A Chicago-based network of primary-care clinics serving the Medicare population is set to move into the Philadelphia market.
The combined system has 43 hospitals, $8 billion in net operating revenue and more than 57,000 employees, including a new leadership team.
The percentage of hospital-employed physicians increased from about 25% in 2010 to more than 40% in 2016, which is associated with a 12% increase in Affordable Care Act premiums, a 9% hike in specialist prices and a 5% boost in primary-care prices from 2013 to 2016, a new study concludes.
The deal, first announced in late May, boosts WellCare's Medicaid membership in Illinois and Michigan and gives it a foundation to build its internal pharmacy management capabilities, which could help the insurer save on prescription drug costs.
Stryker Corp. has agreed to acquire K2M Group Holdings, a key player in the spinal medical device industry, for $1.4 billion.